Volume 20, Number 3—March 2014
CME ACTIVITY - Research
Use of Drug-Susceptibility Testing for Management of Drug-Resistant Tuberculosis, Thailand, 2004–2008
Table 1
Characteristic | Patients with RIF-resistant TB, n = 121 |
Patients with MDR TB, n = 369 |
Patients with RIF-resistant vs. MDR TB, p value‡ | ||||||
---|---|---|---|---|---|---|---|---|---|
Included, n = 36 | Excluded, n = 85 | P value† | Included, n = 172 | Excluded, n = 197 | P value† | ||||
Age, median (IQR), y | 42 (34–58) | 36 (29–48) | 0.02 | 39 (29–50) | 36 (28–47) | 0.11 | 0.10 | ||
Sex | |||||||||
M | 22 (61.1) | 55 (64.7) | 0.71 | 117 (68.0) | 128 (65.0) | 0.58 | 0.42 | ||
F | 14 (38.9) | 30 (35.3) | 55 (32.0) | 68 (34.5) | |||||
Data missing |
0 (0.0) |
0 (0.0) |
0 (0.0) |
1 (0.5) |
|||||
Marital status | |||||||||
Married | 22 (61.1) | 39 (46.4) | 0.32 | 93 (54.1) | 85 (43.1) | 0.001 | 0.06 | ||
Single/divorced/widowed | 13 (36.1) | 43 (51.2) | 79 (45.9) | 98 (50.0) | |||||
Data missing |
1 (2.8) |
2 (2.4) |
0 (0.0) |
13 (6.6) |
|||||
Nationality | |||||||||
Thai | 33 (91.7) | 76 (89.4) | 0.70 | 144 (83.7) | 170 (86.3) | 0.49 | 0.22 | ||
Not Thai | 3 (8.3) | 9 (10.6) | 28 (16.3) | 27 (13.7) |
*Patients were from the Thailand TB Active Surveillance Network and were either included or not included in the current study. Data are no. (%) unless otherwise indicated. TB, tuberculosis; RIF, rifampin; MDR, multidrug-resistance; IQR, interquartile range.
†p values reflect comparison between included and excluded patients in each TB drug resistance group.
‡p values reflect comparison between included RIF-resistant patients and MDR TB patients.
Page created: February 25, 2014
Page updated: February 25, 2014
Page reviewed: February 25, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.